IMPROVING TIME TO ANTICOAGULATION IN PATIENTS WITH PULMONARY EMBOLISM

被引：0
|
作者：
Steinbacher, Donna [1 ]
Barnett, Merry Ellen [2 ]
Griffin, Mary Lewis [2 ]
Hedrick, Amanda [2 ]
机构：
[1] Univ North Carolina Hosp, Chapel Hill, NC USA
[2] UVA Hlth, Charlottesville, VA USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
987
引用
收藏
页码：486 / 486
页数：1
相关论文
共 50 条
  • [41] Concomitant pulmonary embolism and aortic dissection: approach to anticoagulation
    Roque, David
    Magno, Pedro
    Ministro, Augusto
    Santos, Miguel
    de Sousa, Marta
    Augusto, Joao
    Morais, Carlos
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2020, 39 (06)
  • [42] HEMOTHORAX - A COMPLICATION OF ANTICOAGULATION FOR SUSPECTED PULMONARY-EMBOLISM
    MORECROFT, JA
    LEA, RE
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1988, 42 (05): : 217 - 218
  • [43] Inferior vena cava filters for HIV infected patients with pulmonary embolism and contraindications to anticoagulation
    Shahmanesh, M
    Brooks, J
    Shaw, PJ
    Miller, RF
    SEXUALLY TRANSMITTED INFECTIONS, 2000, 76 (05) : 395 - 397
  • [44] Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation
    Westafer, Lauren M.
    Vinson, David R.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (04) : W13 - W13
  • [45] AUDIT OF COMPLIANCE & POTENTIAL COMPLICATIONS OF EMPIRICAL ANTICOAGULATION IN PATIENTS WITH HIGH PROBABILITY OF PULMONARY EMBOLISM
    Shif, Mohd M.
    Rose, A.
    Woodman, R.
    Hakendorf, P.
    Mangoni, A.
    RESPIROLOGY, 2014, 19 : 72 - 72
  • [46] Early versus delayed oral anticoagulation in patients with acute pulmonary embolism: determinants and outcome
    Becattini, C.
    Cimini, L. A.
    Lankeit, M.
    Pruszczyk, P.
    Vanni, S.
    Nazerian, P.
    Kozlowska, M.
    Casula, C.
    Vinci, A.
    Ottaviani, M.
    Coppa, A.
    Vedovati, M. C.
    Agnelli, G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3460 - 3460
  • [47] Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism receiving anticoagulation
    Zalunardo, B.
    Farge-Bancel, D.
    Trujillo-Santos, J.
    Debourdeau, P.
    Bura-Riviere, A.
    Rodriguez-Beltran, E. M.
    Di Micco, P.
    Visona, A.
    Zeltser, D.
    Monreal, M.
    THROMBOSIS RESEARCH, 2014, 133 : S181 - S182
  • [48] Adequate anticoagulation and ECMO therapy in COVID-19 patients with severe pulmonary embolism
    Gaisendrees, Christopher
    Walter, Sebastian G.
    Elderia, Ahmed
    Vollmer, Mattias
    Kaya, Suereyya
    Djordjevic, Ilija
    Eghbalzadeh, Kaveh
    Sabashnikov, Anton
    Kahlert, Heike Anelie
    Deppe, Antje-Christin
    Boll, Boris
    Madershahian, Navid
    Wahlers, Thorsten
    PERFUSION-UK, 2021, 36 (06): : 575 - 581
  • [49] DO PATIENTS WITH AN ASYMPTOMATIC SUB-SEGMENTAL PULMONARY EMBOLISM NEED ANTICOAGULATION THERAPY?
    Choi, Hyun
    Morgan, C.
    EMERGENCY MEDICINE JOURNAL, 2014, 31 (09) : 769 - +
  • [50] Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?
    Leentjens, Jenneke
    Peters, Mike
    Esselink, Anne C.
    Smulders, Yvo
    Kramers, Cornelis
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (11) : 2356 - 2366
12345